In vitro metabolism of 6-mercaptopurine by human liver cytosol

References

• ABRAHAM, E. T., BENSON, L. M. and JARDINE, I., 1983, Synthesis and pH dependent stability of purine-6-sulfenic acid, a putative reactive metabolite of 6-thiopurine. Journal of Medicinal Chemistry, 26, 1523–1526.
   PubMed Web of Science ®Google Scholar
• ADAMSON, P. C., BALIS, F. M., STEINBERG, S. M. and POPLACK, D. G., 1990, Pharmacokinetics of mercaptopurine in children with acute lymphoblastic leukaemia. New England Journal of Medicine, 323, 1565–1566.
   PubMedGoogle Scholar
• BERGAN, S., BENTDAL 0., SODAL, G., BRUN, A., RUGSTAD, H. E. and STOKICE O., 1997, Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes: Relevance to toxicity and monitoring in recipients of renal transplants. Therapeutic Drug Monitoring, 19, 502–509.
   Google Scholar
• BERGMANN, F. and UNGAR, H., 1960, The enzymatic oxidation of 6-mercaptopurine to 6-thiouric acid. Biochimica et Biophyska Acta, 33, 3957–3959.
   Google Scholar
• BOULlEU, R. and LENOIR, A., 1995, Determination of thiopurine nucleotides in human lung tissue by high-performance liquid chromatography. Journal of Chromatography, Biomedical Applications, 665, 213–216.
   Google Scholar
• CARNEY, D. M., ZUKOWSKI, C. F. and OGDEN D. A., 1974, Massive azathioprine overdose. American Journal of Medicine, 56, 133–136.
   Google Scholar
• CUFFARI C., SEIDMAN, E. G., LATOUR, S. and THEORET, Y., 1996, Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercatopurine therapy. Canadian Journal of Physiology and Pharmacology, 74, 580–585.
   Google Scholar
• EmoN, G. B., CALLAHAN, S. W. and HITCHINGS, G. H., 1962, Experimental, clinical and metabolic studies of thiopurines. Cancer Chemotherapy Reports, 16, 197–202.
   PubMedGoogle Scholar
• ELION, G. B., 1967, Biochemistry and pharmacology of purine analogues. Federation. Proceedings, 26, 898–904.
   PubMedGoogle Scholar
• EVANS, W. E., HORNER, M. H., CHU, Y. Q., KALWINSKY, D. and ROBERTS, W. M., 1991, Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyl-transferase deficient child with acute lymphoblastic leukaemia. Journal of Pediatrics, 119, 985–989.
   PubMed Web of Science ®Google Scholar
• GUERCIOLINI, R., SZUMLANSKI, C. L. and WEINSHILBOUM, R. M., 1991, Human liver xanthine oxidase: nature and extent of individual variation. Clinical Pharmacology and Therapeutics, 50, 663–672.
   PubMed Web of Science ®Google Scholar
• HAYDER, S., LAFOLIE, P., BJORK, 0. and PETERSON, C., 1989,6-Mercaptopurine plasma levels in children with acute lymphoblastic leukaemia: relation to relapse risk and myelotoxicity. Therapeutic Drug Monitoring, 11, 617–622.
   Google Scholar
• HEMMENS, V. J. and MOORE, D. E., 1984, Photo-oxidation of 6-mercaptopurine in aqueous solution. Journal of the Chemical Society, Perkin Transactions, 11, 209–211.
   Google Scholar
• HENDRICK, D. and MIRKIN, B. L., 1984, Metabolic disposition and toxicity of 6-mercaptopurine after a massive overdose. Lancet, i (8371), 277.
   Google Scholar
• HON, Y. Y. and EVANS, W. E., 1998, Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach. Clinical Chemistry, 44, 388–400.
   PubMed Web of Science ®Google Scholar
• HYSLOP, R. M. and JARDINE, I., 1981, Metabolism of 6-thiopurines I. Irreversible binding of a metabolite of 6-thiopurine to mammalian hepatic protein in vitro. Journal of Pharmacology and Experimental Therapeutics 218,621–628.
   PubMed Web of Science ®Google Scholar
• KEUZENKAMP -JANSEN, C. W., VAN BAAL, J. M., DE ABREU, R. A., DE JONG, J. G. N., ZUIDERENT, R. and TRUBELS, J. M. F., 1996, Detection and identification of 6-methylmercaptopurine, a major metabolite of 6-mercaptopurine, in plasma during intravenous administration. Clinical Chemistry, 42, 380–386.
   Google Scholar
• KOREN, G., FERRAZINI, G., SULH, H., LANGEVIN, A. M., KAPELUSHNIK J., KLEIN, J., GlESBRECHT, E. SOLDIN, S. and GREENBERG, M., 1990, Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukaemia in children. New England Journal of Medicine, 323, 17–21.
   Google Scholar
• KRENITSKY, T. A., NEIL, S. M., ELION, G. B. and HITCHINGS, G. H., 1972, A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Archives of Biochemistry and Biophysics, 150, 585–599.
   PubMed Web of Science ®Google Scholar
• LENNARD, L., VAN LOON, J. A. and WEINSHILBOUM, R. M., 1989, Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism. Clinical Phar-macology and Therapeutics, 46, 149–154.
   PubMed Web of Science ®Google Scholar
• LENNARD, L., LILLEYMAN, J. S., VAN LOON, J. A. and WEINSHILBOUM, R. M., 1990, Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet, 336,225–229.
   PubMed Web of Science ®Google Scholar
• LENNARD, L. and SINGLETON, H., 1992, High-performance liquid chromatography assay of the methyl and nucleotide metabolites of 6-mercaptopurine : quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinisinic acid and 6-methylmercaptopurine. Journal of Chromatography, Biomedical Applications, 583, 83–90.
   PubMed Web of Science ®Google Scholar
• LENNARD, L. and SINGLETON, H., 1994, High-performance liquid chromatographic assay of human red blood cell thiopurine methyltransferase activity. Journal of Chromatography, Biomedical Appli-cations, 661, 25–33.
   PubMedGoogle Scholar
• LENNARD, L., LEWIS, I. J., MICHELANGNOLI, M. and LILLEYMAN, J. S., 1997, Thiopurine methyl-transferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies. Medical and Pediatric Oncology, 29, 252–255.
   PubMedGoogle Scholar
• LILLEYMAN, J. S. and LENNARD, L., 1994, Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet, 343, 1188–1190.
   PubMedGoogle Scholar
• LILlEMARK, J., PETTERSSON, B. and PETERSON, C., 1992, On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukaemia cells in vitro. Leukaemia Research, 16, 275–280.
   PubMedGoogle Scholar
• LOWRY, 0. H., ROSEBURGH N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• McLEDD, H. L., RELLING, M. V., LIU, Q., Put, C. H. and EVANS, W. E., 1995, Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood, 7, 1897–1902.
   Google Scholar
• NELSON, D. J., BUGGE, C. and KRASNY, H. C., 1977, Oxypurine and 6-thiopurine nucleoside triphosphate formation in human erythrocytes. Advances in Experimental Medicine and Biology, 76A, 121–128.
   PubMedGoogle Scholar
• RELLING, M. V., LIN, J.-S., AYERS, G. and EVANS, W. E., 1992, Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clinical Pharmacology and Therapeutics, 52, 643–658.
   Google Scholar
• RUNDLES, R. W. and ELION, G. B., 1984, Mercaptopurine bioavailability'. New England Journal of Medicine, 310, 929.
   PubMedGoogle Scholar
• SKIPPER, H. E., SCHABEL, F. M. and WiLcox, W. S., 1967, Experimental evaluation of potential anticancer drugs. Cancer Chemotherapy Reports, 51, 125–141.
   PubMedGoogle Scholar
• STET, E. H., DE ABREU, R. A., BOKICERINK, J. P. M., BLOM, H. J., LAMBOOY, L. H. J., VOGELS -MENTINK T. M., DE GRAAF-HESS, A. C., VAN RAAY-SELTEN, B. and TRIJBELS, F. J. M., 1994, Decrease in S - adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts. Biochemical Journal, 304, 163–168.
   Google Scholar
• SZUMLANSKI, C. L., HONCHEL, R., SCOTT, M. C. and WEINSHILBOUM, R. M., 1992, Human liver thiopurine methyltransferase pharmacogenetics : biochemical properties, liver-erythrocyte cor-relation and presence of isozymes. Pharmacogenetics, 2, 148–159.
   PubMedGoogle Scholar
• SZUMLANSKI, C., OTTERNESS, D., HER, C., LEE, D., BRAND1FF KELSELL, D., SPURR, N., LENNARD, WlEBEN, E. and WEINSHILBOUM, R. M., 1996, Thiopurine methyltransferase pharmacogenetics : human gene cloning and characterization of a common genetic polymorphism. DNA and Cell Biology, 15, 17–30.
   Google Scholar
• TIDD, D. M. and PATERSON, A. R. P., 1974, A biochemical mechanism for the delayed cytotoxic reactions of 6-mercaptopurine. Cancer Research, 34, 738–746.
   PubMed Web of Science ®Google Scholar
• WEINSHILBOUM, R. M. and SLADEK, S. L., 1980, Mercaptopurine pharmacogenetics : monogenic inheritance of erythrocyte thiopurine methyltransferase activity. American Journal of Human Genetics, 32, 651–662.
   PubMed Web of Science ®Google Scholar
• WEINSHILBOUM, R. M., 1992, Methylation pharmacogenetics : thiopurine methyltransferase as a model system. Xenobiotka, 22, 1055–1071.
   PubMed Web of Science ®Google Scholar
• ZDA:m, S., COLLINS, J. M., RICCARDI, R., O'NEILL, D., NARANG, P. K., CHABNER, B. and POPLACK, D. G., 1983, Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukaemia being optimally delivered? New England Journal of Medicine, 308, 1005–1009.
   Google Scholar